1/17/2018Amarin Announces Commencement of VASCEPA Clinical Development in Mainl...

1/17/2018China's Medical Representative Registration System: Action Items for P...

1/17/20183SBio Licenses Mainland China Rights of Toray's Antipruritic Agent TRK...

1/16/2018Clinical Trials Registered on the CDE Platform Rebound to a New Peak i...

1/16/2018Data Snapshot: Overseas Out-licensing Deals of Novel Drugs Developed i...

1/15/2018Overview of Chinese Drug Approvals in 2017

1/15/2018CFDA Releases List of Newly Approved Professional Journals Approved fo...

1/12/2018BeiGene and Mirati Announce Exclusive License Agreement for Sitravatin...

1/11/2018CFDA Seeks Comments on the Amendments of Administrative Measures for D...

1/11/2018Recent Executive Moves

1/11/2018Ten Contemporary Chinese Biopharma Industry Predictions in 2018

1/10/2018Data Snapshot: Chinese Hospital Consumption of Cholesterol-Reduction D...

1/10/2018Indigenously-developed Class 1 New Chemical Drugs Approved in China 20...

1/10/2018CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat in 2017

1/10/2018Numerous Provinces Expand Disease Group-Based BMI Payment Scheme at th...

1/9/2018BeiGene and Boehringer Enter Supply Agreement for Anti-PD-1 Antibody T...

1/8/2018Merus and Simcere Announce Strategic Collaboration on Multiple Bispeci...

1/8/2018NHFPC Outlines Ten Areas of Reform Action in the New Year

1/8/2018MNCs Reorganize and Launch New Products in China

1/8/2018CFDA Solicits Comments on Drug Data Management Guidelines

1/5/2018Biostage Raises $4.2M from Chinese Investor Group

1/4/2018Recent Executive Moves

1/4/2018Amendments Of Anti-Unfair Competition Law

1/4/2018Roche's NDA for Breast Cancer Drug Perjeta Accepted in China

1/4/2018Novartis Lost Gleevec Infringement Lawsuit in China against Jiangsu Ha...

1/4/2018Angiochem and Xinogen Enter License Agreement for Breast Cancer Drug C...

1/3/2018CFDA Issues Guidelines for Clinical Trials of Overactive Bladder Drugs

1/3/2018CDMO CMAB Closes US$38 Million Series A Financing Round

1/3/2018BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...

1/2/2018China FDA Solicits Comments on Conditional Approvals for New Drugs and...

Page:147/334 Total number of articles:10001: [First][<<] [145] [146] [147] [148] [149] [>>] [End]